
    
      Italy was the first European country hit by the severe outbreak of the SARS-CoV-2 epidemic
      emerged from China, with a high morbidity and associated mortality.

      Given the limited treatment options currently available, the search for resources capable of
      improving disease outcomes is fundamental for the management of patients

      Systemic inflammation related to COVID-19, dietary changes, and use of antibiotics are all
      variables that contribute to changes in the gut microbiota with significant impact on the
      disease outcomes. Probiotic supplementation can help to correct these issues.

      Moreover some strains of lactobacilli and bifidobacteria inhibit influenza virus, rhinovirus,
      respiratory syncytial virus, adenovirus, and pneumovirus .
    
  